Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.340 NOK
−189.24 M NOK
0.00 NOK
14.96 M
About ULTIMOVACS ASA
Sector
CEO
Carlos de Sousa
Headquarters
Oslo
Website
Founded
2011
ISIN
NO0010851603
FIGI
BBG00P7CR5H1
Ultimovacs AS operates as a pharmaceutical company. The firm engages in the development of novel immunotherapies against cancer. Its product, UV1, is a therapeutic cancer vaccine that activates the immune system to recognize telomerase. The company was founded on January 26, 2011 and is headquartered in Oslo, Norway.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ULTI is 2.015 NOK — it has decreased by −1.21% in the past 24 hours. Watch ULTIMOVACS ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange ULTIMOVACS ASA stocks are traded under the ticker ULTI.
ULTI stock has fallen by −0.49% compared to the previous week, the month change is a 13.33% rise, over the last year ULTIMOVACS ASA has showed a −98.22% decrease.
We've gathered analysts' opinions on ULTIMOVACS ASA future price: according to them, ULTI price has a max estimate of 7.00 NOK and a min estimate of 2.50 NOK. Watch ULTI chart and read a more detailed ULTIMOVACS ASA stock forecast: see what analysts think of ULTIMOVACS ASA and suggest that you do with its stocks.
ULTI reached its all-time high on Oct 18, 2023 with the price of 178.600 NOK, and its all-time low was 1.570 NOK and was reached on Oct 10, 2024. View more price dynamics on ULTI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ULTI stock is 12.45% volatile and has beta coefficient of 1.21. Track ULTIMOVACS ASA stock price on the chart and check out the list of the most volatile stocks — is ULTIMOVACS ASA there?
Today ULTIMOVACS ASA has the market capitalization of 70.17 M, it has increased by 29.57% over the last week.
Yes, you can track ULTIMOVACS ASA financials in yearly and quarterly reports right on TradingView.
ULTIMOVACS ASA is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ULTI net income for the last quarter is −25.83 M NOK, while the quarter before that showed −44.77 M NOK of net income which accounts for 42.31% change. Track more ULTIMOVACS ASA financial stats to get the full picture.
No, ULTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 25.00 employees. See our rating of the largest employees — is ULTIMOVACS ASA on this list?
Like other stocks, ULTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ULTIMOVACS ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ULTIMOVACS ASA technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ULTIMOVACS ASA stock shows the sell signal. See more of ULTIMOVACS ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.